To see all protocols that comply with the WHO Essential Medicine List 

This resource provides guidance on how to safely undertake the procedure. Institutional practice may vary in accordance with local policy.

Only health care professionals who have attained competency (as per institutional guidelines) should perform this procedure.

Aseptic Non Touch Technique (ANTT®) used for this procedure includes Standard-ANTT® and Surgical-ANTT® r

Standard-ANTT® is a framework and management approach for relatively simple and shorter invasive procedures.

The aim is to maintain asepsis of all Key-Parts using standard precautions (e.g. hand hygiene and non-sterile gloves), a General Aseptic Field (e.g. decontaminated and disinfected procedure tray) and Key-Part Protection by Micro-Critical Aseptic Fields (e.g. sterile caps on syringe tip, inside of recently opened sterile packaging) and non-touch technique.

Surgical-ANTT® is a framework and management approach for more technically challenging or longer procedures with numerous Key-Parts and Key-Sites.

The aim is to maintain asepsis of all Key-Parts and Key-Sites using standard precautions (e.g., hand hygiene and sterile gloves) and Critical Aseptic Field management (e.g., sterile drape, dressing pack).

If TIVAD is to remain accessed: use Surgical-ANTT®

If TIVAD is to be accessed, flushed, locked and deaccessed either: Standard-ANTT® or Surgical-ANTT® can be used. Refer to local policy.

Related eLearning: 
Central venous access devices
Accessing and deaccessing a TIVAD (video)
Flushing and locking (video)

This document reflects what is currently regarded as safe practice. While every effort has been made to ensure the accuracy of the content at the time of publication, the Cancer Institute NSW does not accept any liability, with respect to loss, damage, injury or expense arising from any such errors or omission in the contents of this work. Any reference throughout the document to specific pharmaceuticals and/or medical products as examples does not imply endorsement of any of these products. While eviQ endeavours to link to reliable sources that provide accurate information, eviQ and the Cancer Institute NSW do not endorse or accept responsibility for the accuracy, currency, reliability or correctness of the content of linked external information source. Use is subject to eviQ’s disclaimer available at

Send feedback for this page

First approved:
Last reviewed:
Review due:

The currency of this information is guaranteed only up until the date of printing, for any updates please check:

29 Feb 2024